ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 371

Inflammatory Cell Infiltrates In The Heart Of Patients With Coronary Artery Disease With and Without Inflammatory Rheumatic Disease: A Biopsy Study

Jacqueline Kirsti Andersen1, Ingvild Oma2, Ingjerd Lien Kveldstad2, Knut Mikkelsen3, Terje Veel4, Sven M. Almdahl5, Matthew H. Liang6, Øystein T. Førre7, Morten Fagerland8 and Ivana Hollan9, 1Gjøvik University College, Gjøvik, Norway, 2Innlandet Hospital Trust, Lillehammer, Norway, 3Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, 4Feiringklinikken, Feiring, Norway, 5Cardiothoracic surgery, University Hospital of North Norway, Tromsø, Norway, 6Harvard Medical School, Boston, MA, 7Oslo University Hospital, Oslo, Norway, 8Department of Biostatistics, Oslo University Hospital, Oslo, Norway, 9Rheumatology, Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: biopsies, coronary artery disease, Inflammation, rheumatic disease and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Systemic rheumatic diseases (SRDs) are associated with increased cardiovascular (CV) morbidity due to accelerated atherosclerosis. However, SRDs are associated also with cardiac vasculitis that may contribute to the increased CV risk (1). The objective is to examine the occurrence and extent of inflammatory cell infiltrates (ICI) and small vessel vasculitis in all layers of the right atrium (epicardium, myocardium and endocardium) in patients with coronary artery disease (CAD) with and without SRDs.

Methods:  We examined biopsies from the right atrium taken in a standardized way during coronary artery bypass grafting from the edge of the openings for cannulation due to extracorporeal circulation from patients with and without SRD (matched for age, sex and acute coronary syndrome) included in Feiring Heart Biopsy Study (2). The specimens were fixed with paraffin and stained by hematoxylin and eosin, and one 3-mm thick section from each specimen was examined by light microscopy in a blinded manner.  The number and extent of ICIs in the three layers of the heart wall were semi-quantified.

Results:

 

IRD (n = 40)

Non-IRD (n = 48)

Fisher mid-p test

Age, mean ± SD (years)

66,83 ± 10,5

66,42 ± 10,2

0.85

Male (%)

27 (67,5)

28 (58,3)

0.39

ICIs of epicardium (%)

24 (60%)

27 (56,2)

0.75

ICIs of myocardium (%)

0 (0%)

3 (6,2%)

0.17

ICIs of endocardium (%)

0 (0%)

1 (2,1%)

0.73

Vasculitis (%)

0 (0%)

0 (0%)

1.00

The infiltrates consisted predominantly of lymphocytes. Perivascular infiltrates occurred in all patients except for one. All the infiltrates in the myocardium were perivascular. There was no significant difference in the scores for the size and number of ICIs in the epicardium between the groups.

Conclusion:  In patients with CAD, vasculitis was not observed, but the occurrence of ICIs in the right atrium was high, mostly localized around small vessels. The ICIs were found predominantly in the epicardium, and the occurrence and extent of epicardial ICIs was similar in SRD and non-SRD patients. In the myocardium and endocardium, the ICIs occurred in a low frequency, and in the non-SRD group only (but the difference was not statistically significant). In theory, the observed ICIs might be secondary to or independent of cardiovascular disease (CVD), but the inflammation might also contribute to CAD by compromising of the function of epicardial coronary arteries. Interestingly, abnormalities in epicardium (increased mass of epiicardial adipose tissue) are related to CV prognosis, and we propose that inflammation in the epicardium might be of particular importance. Our findings do not support the hypothesis that inflammation in the heart including small vessel cardiac vasculitis is more common in SRD than non-SRD patients. However, this possibility cannot be completely ruled out as the number of examined specimens were small, taken from apparently healthy tissue, and the right atrium was the only site sampled.

References:
(1) Bely M, Apathy A. Orv Hetil 1996; 137(29):1571-8
(2) Hollan I et al. Arthritis Rheum 2007; 56: 20072-9


Disclosure:

J. K. Andersen,
None;

I. Oma,
None;

I. Lien Kveldstad,
None;

K. Mikkelsen,
None;

T. Veel,
None;

S. M. Almdahl,
None;

M. H. Liang,
None;

T. Førre,
None;

M. Fagerland,
None;

I. Hollan,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inflammatory-cell-infiltrates-in-the-heart-of-patients-with-coronary-artery-disease-with-and-without-inflammatory-rheumatic-disease-a-biopsy-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology